Alan Mendelsohn insider trades: Timber Pharmaceuticals (TMBR) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Alan reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 23, 2021 | TMBR | ↑ Buy | 10,000 | $0.47 | $5K | Direct | Nov 24, 2021 (1d) |
| Mar 3, 2021 | TMBR | ↑ Buy | 1,988 | $2.17 | $4K | By spouse | May 13, 2021 (71d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Alan Mendelsohn's insider trades
Alan Mendelsohn is EVP & CMO at Timber Pharmaceuticals (TMBR). Since Mar 3, 2021, Alan has reported 2 open-market purchases worth $9K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TMBR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.